MEK/ERK and Signal Transducer and Activator of Transcription Signaling Pathways Modulate Oncostatin M-Stimulated CCL2 Expression in Human Osteoblasts Through a Common Transcription Factor

Arthritis and Rheumatism

Volumn 50, Issue 3, 2004, Pages 785-793

  Lin, Sze Kwan ^a   Kok, Sang Heng ^a   Tzu Chin Yeh, Flora ^a   Kuo, Mark Yen Ping ^a   Lin, Ching Chuan ^a   Wang, Chih Chiang ^a   Goldring, Steven R ^b   Hong, Chi Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CURCUMIN; DNA; FLUDARABINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M; PICEATANNOL; PROTEIN KINASE; PROTEIN TYROSINE KINASE; STAT PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE C FOS; OSTEOBLAST; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELLS, CULTURED; CHEMOKINE CCL2; CYCLOOXYGENASE 2; DNA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOSTATIN M; OSTEOBLASTS; PEPTIDES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 1542283758     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20058     Document Type: Article

References (44)

1. Langdon C, Leith J, Smith F, Richards CD. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase 1 production by human synovial fibroblasts in vitro. Arthritis Rheum 1997;40:2139-46.
2. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1989;1:2-13.
3. Erwig LP, Kluth DC, Rees AJ. Macrophages in renal inflammation. Curr Opin Nephrol Hypertens 2001;10:341-7.
4. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991;9:617-48.
5. Volejnikova S, Laskari M, Marks SC Jr, Graves DT. Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse. Am J Pathol 1997;150:1711-21.
6. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996;2:198-204.
7. Heymann D, Rousselle AV. gp130 cytokine family and bone cells. Cytokine 2000;12:1455-68.
8. Hui W, Bell M, Carroll G. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants. Cytokine 1996;8:495-500.
9. Li WQ, Dehnade F, Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 gene expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 2001;166:3491-8.
10. Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, et al. Regulation of inflammatory responses by oncostatin M. J Immunol 1999;162:5547-55.
11. Li WQ, Zafarullah M. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms. J Immunol 1998;161:5000-7.
12. Lisignoli G, Toneguzzi S, Pozzi C, Piacentini A, Riccio M, Ferruzzi A, et al. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1999;26:791-9.
13. Rahimi P, Wang CY, Stashenko P, Lee SK, Lorenzo JA, Graves DT. Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology 1995;136:2752-9.
14. Williams SR, Jiang Y, Cochran D, Dorsam G, Graves DT. Regulated expression of monocyte chemoattractant protein-1 in normal human osteoblastic cells. Am J Physiol 1992;263:C194-9.
15. Zhu JF, Valente AJ, Lorenzo JA, Carnes D, Graves DT. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res 1994;9:1123-30.
16. Langdon C, Kerr C, Hassen M, Hara T, Arsenault AL, Richards CD. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 2000;157:1187-96.
17. Day RO. Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspective. Clin Exp Rheumatol 2001;19:S59-62.
18. Lin SK, Kok SH, Kuo MY, Wang TJ, Wang JT, Yeh FT, et al. Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats. Eur J Oral Sci 2002;110:246-53.
19. Janabi N, Hau I, Tardieu M. Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes. J Immunol 1999;162:1701-6.
20. Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, et al. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 2001;33:713-21.
21. Uehara Y, Fukazawa H. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991;201:370-9.
22. 2 in human synovial fibroblasts. J Cell Biochem 1995;57:619-29.
23. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999;5:444-7.
24. Fagard R, Mouas H, Dusanter-Fourt I, Devillers C, Bissieres P, Martin A, et al. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. Oncogene 2002;21:4473-80.
25. Su L, David M. Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor: selective inhibition of STAT3 and STAT5 by piceatannol. J Biol Chem 2000;275:12661-6.
26. Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001;61:5137-44.
27. McGee MM, Campiani G, Ramunno A, Nacci V, Lawler M, Williams DC, et al. Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells. J Biol Chem 2002;277:18383-9.
28. Huang TS, Lee SC, Lin JK. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci U S A 1991;88:5292-6.
29. Gearing DP. The leukemia inhibitory factor and its receptor. Adv Immunol 1993;53:31-58.
30. Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 1994;269:6215-22.
31. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 1996;97:431-7.
32. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A 1992;89:4888-92.
33. Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, et al. Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 1995;96:923-30.
34. Satoh T, Uehara Y, Kaziro Y. Inhibition of interleukin 3 and granulocyte-macrophage colony-stimulating factor stimulated increase of active ras.GTP by herbimycin A, a specific inhibitor of tyrosine kinases. J Biol Chem 1992;267:2537-41.
35. Gentili C, Boland R, de Boland AR. PTH stimulates PLCβ and PLCγ isoenzymes in rat enterocytes: influence of ageing. Cell Signal 2001;13:131-8.
36. Munoz E, Beutner U, Zubiaga A, Huber BT. IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 1990;144:964-9.
37. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000;351:289-305.
38. Bellido T, Borba VZ, Roberson P, Manolagas SC. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 1997;138:3666-76.
39. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-6.
40. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A 1991;88:3720-4.
41. Van Dam H, Castellazzi M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 2001;20:2453-64.
42. Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 1992;358:414-7.
43. Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993;73:381-93.
44. Catterall JB, Carrere S, Koshy PJ, Degnan BA, Shingleton WD, Brinckerhoff CE, et al. Synergistic induction of matrix metalloproteinase 1 by interleukin-1α and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 2001;44:2296-310.